INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
ME
Marchetti Dominick EdilioChief Digital Officer
LDIloanDepot, Inc.
Grant or award
A—
393.1K sh
Aug 5, 2026Aug 7, 2026
Page 553 of 1701
← PrevNext →
traded Aug 5, 2026
+2d
SEC Form 4

Evidence

9
LC
Ledbetter Samuel CraigSVP Chief Supply Chain Officer
TSCOTRACTOR SUPPLY CO /DE/
Grant or award
A—
9,214 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
GY
Garten YaelDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
156 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
KJ
Kong-Picarello JenniferSenior Vice President, CFO
TEXTEREX CORP
Grant or award
A$1,328
20 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
MJ
Ming Jenny JDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
104 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
MJ
Ming Jenny JDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
54 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
PE
Prime Joshua EDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
106 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
GJ
Grassi Joseph J IIIChief Legal & Risk Officer
LDIloanDepot, Inc.
Grant or award
A—
102.2K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

9
GC
Gallagher CindyCAO
TDAYUSA TODAY Co., Inc.
Option exercise
M—
9,070 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

9
ZE
Zitting Shaun EllenChief Human Resources Officer
NIQNIQ Global Intelligence plc
Tax withholding
F$18K
1,516 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

8
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$170K
5,849 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

8
HG
Harrison GinaVP and Corporate Controller
QRVOQorvo, Inc.
Tax withholding
F$51K
534 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

8
PS
Pearce SamanthaEVP, Chief Commercial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$204K
780 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

8
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$405K
25.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

8
MB
Mintz William B.SVP, Chief Strategy Officer
CTEVClaritev Corp
Tax withholding
F$95K
3,622 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

8
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$273K
9,292 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

7
MA
Medway Richard A.General Counsel
SVVSavers Value Village, Inc.
Option exercise · 10b5-1 plan
M$33K
23.3K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC Form 4

Evidence

7
BP
Buckley Sean PatrickSee Remarks
MGNIMAGNITE, INC.
Option exercise · 10b5-1 plan
M—
28.7K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

7
GL
Geisser Melinda L.Chief People Services Officer
SVVSavers Value Village, Inc.
Option exercise · 10b5-1 plan
M$21K
15.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

7
MA
Mayes Patrick AEVP & Chief Scientific Officer
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$274K
2,207 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

7
WD
Werner Ryan D.SVP, CAO
RIOTRiot Platforms, Inc.
Open-market sale · 10b5-1 plan
SELL$779K
35.4K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

6
RN
Reskos NikolaosChief Operating Officer
SBLKStar Bulk Carriers Corp.
Open-market sale · 10b5-1 plan
SELL$148K
5,000 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

6
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$170K
20.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

6
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$346K
18.3K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

6
MA
Medway Richard A.General Counsel
SVVSavers Value Village, Inc.
Option exercise · 10b5-1 plan
M$53K
16.7K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC Form 4

Evidence

6
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$255K
14.3K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

6
BN
Baruch NiranChief Financial Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$19K
1,875 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

6
BN
Baruch NiranChief Financial Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$18K
1,875 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

6
AL
Aldema LiorEVP and Chief Business Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$28K
2,812 sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

6
AL
Aldema LiorEVP and Chief Business Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$28K
2,812 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

5
DM
DerGurahian Jeffrey MichaelChief Investment Officer
LDIloanDepot, Inc.
Grant or award
A—
157.2K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

5
CP
Coyne Terrance P.EVP & CFO
RPRXRoyalty Pharma plc
Gift
G—
18.5K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$962
27 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

5
VE
Vivas EduardoDirector
APPAppLovin Corp
Gift
G—
213.7K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC Form 4

Evidence

5
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$145K
5,000 sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

5
VE
Vivas EduardoDirector
APPAppLovin Corp
Gift
G—
213.7K sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC Form 4

Evidence

5
UM
Urist MarshallEVP, Research & Investments
RPRXRoyalty Pharma plc
Gift
G—
3,000 sh
Aug 7, 2026Aug 7, 2026
traded Aug 7, 2026
+0dSEC Form 4

Evidence

5
BP
Buckley Sean PatrickSee Remarks
MGNIMAGNITE, INC.
Option exercise · 10b5-1 plan
M$399K
28.7K sh
Aug 6, 2026Aug 7, 2026
traded Aug 6, 2026
+1dSEC Form 4

Evidence

5
DM
DerGurahian Jeffrey MichaelChief Investment Officer
LDIloanDepot, Inc.
Disposition to issuer
D—
157.2K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence

5
DM
DerGurahian Jeffrey MichaelChief Investment Officer
LDIloanDepot, Inc.
Grant or award
A—
750.0K sh
Aug 5, 2026Aug 7, 2026
traded Aug 5, 2026
+2dSEC Form 4

Evidence